Clarinex-D 24 Hour (desloratadine/pseudoephedrine sulfate)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

USES: This medication is used to relieve allergy symptoms such as watery eyes, runny/stuffy nose, itching eyes/nose, and sneezing. It contains 2 medications: desloratadine and pseudoephedrine. Desloratadine is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction.

Pseudoephedrine is a decongestant and works by narrowing the blood vessels in the nose to decrease swelling and congestion. This medication is not recommended for use in children younger than 12 years of age due to the large amount of pseudoephedrine in it.

Generic name: desloratadine/pseudoephedrine sulfate
Pronunciation: (des-lor-AT-uh-deen/sue-doh-eff-ED-rin)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Clarinex-D 24 Hour

Intelligence content is not available yet.

Indications

The following indications are listed for Clarinex-D 24 Hour:

  • Allergic Conjunctivitis
  • Allergic Rhinitis
  • Cold Symptoms
  • Nasal Congestion
  • Perennial Allergic Rhinitis
  • Rhinorrhea
  • Seasonal Allergic Rhinitis
  • Sneezing
  • Vasomotor Rhinitis

Also known as: Allergy Eye Itch, Atopic Conjunctivitis, Atopic Rhinitis, Intermittent Allergic Rhinitis, Itchy Eyes Due To Allergies, Nasal Stuffiness, Non-Seasonal Allergic Rhinitis, Ocular Itching Due To Allergies, Periodic Runny Nose, Seasonal Allergy.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data